CCTG 594: Engagement and Retention in Care for HIV+

Inclusion Criteria: * HIV-1 infection, as documented by any licensed screening antibody test, such as ELISA, and confirmed by a second antibody test, such as Western blot, or detectable plasma HIV-1 RNA at any time prior to study entry. If an ELISA or Western blot is not available, HIV infection may be documented by two HIV RNA values ≥2000 copies/mL, drawn at least 24 hours apart. The RNA assays must have been run at a CLIA-approved laboratory or equivalent. * 18 years of age or older. * Able to give written informed consent. * New patient to the clinic (defined as someone who has never engaged in HIV care) or a patient returning to care (defined as a patient previously seen at least once by a prescribing HIV provider who has not seen a prescribing HIV provider in the last 180 days and is not on a stable ARV regimen). * English or Spanish Speaking. * Registered to receive HIV primary care services at one of the identified CCTG-affiliated clinic, i.e. the Owen Clinic at UC San Diego Health System, Harbor-UCLA Medical Center clinic or Rand Schrader clinic at USC. Exclusion Criteria: * Unstable neurologic, psychiatric, or physical condition which, in the opinion of the investigator, would limit participation with study procedures for the duration of the study. * A level of drug or alcohol use that, in the opinion of the investigator, would preclude safe participation in the study. * Resident of nursing home or skilled facility. * Pregnant or breastfeeding. * Patient's first primary care visit (for new patients) or return to care visit (for patients returning to care) occurred \> 60 days ago.